Keyphrases
5-aminolevulinate
50%
5-Aminolevulinic Acid (5-ALA)
16%
Age-adjusted
13%
Amiodarone
25%
Anorectal Function
50%
Antidepressants
25%
Antioxidant Properties
16%
Antipsychotics
25%
Bronchodilator
25%
Clinical Practice
25%
Constipation
50%
Cortical Evoked Potentials
13%
Dichloroacetate
33%
Drug-induced Tremor
50%
Gastrointestinal Diseases
9%
Glial Cells
16%
Gut-brain Axis
50%
Heme Precursors
50%
Hydroxynonenal
16%
Investigational Drugs
16%
Lipids
33%
Lithium
25%
Malondialdehyde
16%
Management Strategy
25%
Mitochondrial Respiratory Chain
16%
Moderate to Severe
9%
Motor Evoked Potential Latency
18%
Multi-session
50%
Myelin
16%
Myelin Formation
50%
Myelin Protein Zero
16%
Neurological Complications
16%
Neuronal Cells
16%
Oxidative Stress Markers
16%
Parkinson's Disease
100%
Parkinson's Disease Model
9%
Peripheral Myelin Protein 22 (PMP22)
16%
Peripheral Neuropathy
16%
Porphyria
16%
Pro-oxidant
16%
Protein Carbonyls
16%
Schwann Cells
50%
Sensory Neurons
16%
Sensory Threshold
13%
Severe Constipation
13%
Symptomatic Patients
25%
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
50%
Tremor
50%
Tyrosinemia Type 1
16%
Valproic Acid
25%
Medicine and Dentistry
Adverse Event
7%
Amiodarone
50%
Antidepressant
50%
Bronchodilating Agent
50%
Clinician
50%
Constipation
50%
Evoked Cortical Response
12%
Gastrointestinal Distress
8%
Gut
50%
Motor Evoked Potential
20%
Myelodysplastic Syndrome
7%
Parkinson's Disease
100%
Perceptive Threshold
12%
Sensation
8%
Sodium Valproate
50%
Symptom
11%
Typical Antipsychotic
50%
Unified Parkinson's Disease Rating Scale
7%
Vagus Nerve Stimulation
50%
Neuroscience
Alpha-Linolenic Acid
50%
Aminolevulinic Acid
50%
Electron Transport Chain
8%
Evoked Cortical Response
12%
Glial Cells
8%
Heme
50%
Motor Evoked Potential
20%
Myelin
8%
Myelin Protein
8%
Myelinogenesis
50%
Oxidative Stress
8%
Oxidizing Agent
16%
Parkinson's Disease
50%
Peripheral Myelin Protein 22
8%
Peripheral Neuropathy
8%
Porphyria
8%
Protein Carbonylation
8%
Schwann Cell
25%
Sensory Neuron
8%
